Nasreen Al-Sayed

851 total citations
12 papers, 287 citations indexed

About

Nasreen Al-Sayed is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Cancer Research. According to data from OpenAlex, Nasreen Al-Sayed has authored 12 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Epidemiology and 3 papers in Cancer Research. Recurrent topics in Nasreen Al-Sayed's work include Diabetes and associated disorders (2 papers), Chronic Disease Management Strategies (2 papers) and Diabetes Management and Education (2 papers). Nasreen Al-Sayed is often cited by papers focused on Diabetes and associated disorders (2 papers), Chronic Disease Management Strategies (2 papers) and Diabetes Management and Education (2 papers). Nasreen Al-Sayed collaborates with scholars based in Bahrain, Saudi Arabia and United Arab Emirates. Nasreen Al-Sayed's co-authors include Ghada Al‐Kafaji, Zuheir Hasan, Sadia Nawaz, Moiz Bakhiet, Wassim Y. Almawi, Ghada Al-Khateeb, Hani Tamim, Michel P. Hermans, Ramesh C. Pandey and Michel Farnier and has published in prestigious journals such as Atherosclerosis, Clinical and Vaccine Immunology and Endocrine Practice.

In The Last Decade

Nasreen Al-Sayed

12 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasreen Al-Sayed Bahrain 6 107 75 71 70 64 12 287
Orestis Manousos Greece 7 105 1.0× 37 0.5× 77 1.1× 80 1.1× 68 1.1× 12 350
Seohyuk Lee United States 9 52 0.5× 23 0.3× 82 1.2× 55 0.8× 71 1.1× 31 284
Anne McGowan United Kingdom 11 147 1.4× 12 0.2× 42 0.6× 53 0.8× 47 0.7× 28 305
Yanying Guo China 10 125 1.2× 29 0.4× 33 0.5× 73 1.0× 64 1.0× 35 406
Cristina Alina Silaghi Romania 9 131 1.2× 14 0.2× 45 0.6× 28 0.4× 99 1.5× 22 265
Abdulrahman Al-Nuaim Saudi Arabia 11 227 2.1× 63 0.8× 63 0.9× 178 2.5× 53 0.8× 24 547
Itahisa Marcelino-Rodríguez Spain 12 58 0.5× 16 0.2× 42 0.6× 42 0.6× 64 1.0× 29 294
Szilvia Fiatal Hungary 13 68 0.6× 14 0.2× 25 0.4× 56 0.8× 45 0.7× 34 337
Chien‐Hsiang Weng United States 10 97 0.9× 47 0.6× 25 0.4× 53 0.8× 26 0.4× 30 320
Orit Twito Israel 10 136 1.3× 11 0.1× 52 0.7× 48 0.7× 42 0.7× 30 271

Countries citing papers authored by Nasreen Al-Sayed

Since Specialization
Citations

This map shows the geographic impact of Nasreen Al-Sayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasreen Al-Sayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasreen Al-Sayed more than expected).

Fields of papers citing papers by Nasreen Al-Sayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasreen Al-Sayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasreen Al-Sayed. The network helps show where Nasreen Al-Sayed may publish in the future.

Co-authorship network of co-authors of Nasreen Al-Sayed

This figure shows the co-authorship network connecting the top 25 collaborators of Nasreen Al-Sayed. A scholar is included among the top collaborators of Nasreen Al-Sayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasreen Al-Sayed. Nasreen Al-Sayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Aguíar, Carlos, Nasreen Al-Sayed, М. В. Ежов, et al.. (2023). Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. Atherosclerosis. 383. 117312–117312. 77 indexed citations
2.
Al-Sayed, Nasreen, et al.. (2021). The gulf association of endocrinology and diabetes is born: History in the making. 4(1). 41–42. 4 indexed citations
3.
Afandi, Bachar, Naji Aljohani, Tarik Elhadd, et al.. (2021). Free communications of the gulf association of endocrinology and diabetes virtual meeting 2021 - October 7–9, 2021. 4(4). 210–231. 1 indexed citations
4.
Al‐Saleh, Yousef, Salem Beshyah, Wiam I. Hussein, et al.. (2020). Diagnosis and management of vitamin D deficiency in the Gulf Cooperative Council (GCC) countries: an expert consensus summary statement from the GCC vitamin D advisory board. Archives of Osteoporosis. 15(1). 35–35. 36 indexed citations
5.
6.
Al-Sayed, Nasreen, et al.. (2016). Abstracts of the fourth clinical congress of the gulf chapter of the American association of clinical endocrinologists; 3-5 November 2016; Dubai, UAE. II. free communications. Ibnosina Journal of Medicine and Biomedical Sciences. 8(6). 298–331. 1 indexed citations
7.
Al‐Kafaji, Ghada, et al.. (2015). Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes. Molecular Medicine Reports. 12(5). 7485–7490. 67 indexed citations
8.
Al‐Ashwal, Abdullah, Fahad Alnouri, Hani Sabbour, et al.. (2015). Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel. Current Vascular Pharmacology. 13(6). 759–770. 23 indexed citations
9.
Al-Sayed, Nasreen, Tianming Gao, Brian J. Wells, Changhong Yu, & Robert S. Zimmerman. (2013). Angiotensin-Converting Enzyme Inhibitors Reduce Albuminuria More than Angiotensin Receptor Blockers in Patients with Type 2 Diabetes. Endocrine Practice. 19(4). 579–586. 1 indexed citations
10.
Almawi, Wassim Y., et al.. (2008). Association of comorbid depression, anxiety, and stress disorders with Type 2 diabetes in Bahrain, a country with a very high prevalence of Type 2 diabetes. Journal of Endocrinological Investigation. 31(11). 1020–1024. 64 indexed citations
11.
Almawi, Wassim Y., et al.. (2006). Association of Selective HLA class II Susceptible and Protective Haplotypes with Type 2 Diabetes in Bahrain and Lebanon. Clinical and Vaccine Immunology. 1 indexed citations
12.
Almawi, Wassim Y., et al.. (2006). Association of Selective HLA Class II Susceptibility-Conferring and Protective Haplotypes with Type 2 Diabetes in Patients from Bahrain and Lebanon. Clinical and Vaccine Immunology. 13(11). 1296–1298. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Orestis Manousos Breakdown of academic impact, for papers by Seohyuk Lee Breakdown of academic impact, for papers by Anne McGowan Breakdown of academic impact, for papers by Yanying Guo Breakdown of academic impact, for papers by Cristina Alina Silaghi Breakdown of academic impact, for papers by Abdulrahman Al-Nuaim Breakdown of academic impact, for papers by Itahisa Marcelino-Rodríguez Breakdown of academic impact, for papers by Szilvia Fiatal Breakdown of academic impact, for papers by Chien‐Hsiang Weng Breakdown of academic impact, for papers by Orit Twito
Rankless by CCL
2026